Home | Welcome to Contract Pharma   
Last Updated Tuesday, June 18 2013
Print

Financial Reports

Related Searches:

Filter by:

Financial Report: Cangene
June 6, 2013
Revenues up 46% in the quarter   Read More »
Financial Report: Patheon
June 3, 2013
Revenues up 40%, boosted by Banner   Read More »
Financial Report: Alkermes
May 23, 2013
Revenues up 25% in the quarter   Read More »
Financial Report: BASi
May 15, 2013
Consolidation efforts impact results   Read More »
Financial Report: WuXi PharmaTech
May 14, 2013
Lab services up 13% in the quarter   Read More »
Financial Report: Anacor Pharmaceuticals
May 10, 2013
Decline in R&D agreements impacts revenues   Read More »
Financial Report: PDL BioPharma
May 10, 2013
Royalty revenues up 19% in the quarter   Read More »
Financial Report: Ligand
May 9, 2013
Revenues double in the quarter   Read More »
Financial Report: Dendreon
May 9, 2013
Revenues down 18% in the quarter   Read More »
Financial Report: AMRI
May 7, 2013
Revenues up 11% in the quarter   Read More »
Financial Report: Gilead Sciences
May 3, 2013
Revenues up 11% in the quarter with antiviral combos   Read More »
Financial Report: Mylan
May 3, 2013
Specialty segment sales up 24% in the quarter   Read More »
Financial Report: Teva
May 2, 2013
Earnings hit by lost generic Lipitor royalties   Read More »
Financial Report: Sanofi
May 2, 2013
Generic competition continues to hurt revenues   Read More »
Financial Report: Covance
May 2, 2013
Late-Stage Development revenues up 17%   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: